skip to content

Chugai Presents Results from Phase III Study of Satralizumab in NMOSD at ECTRIMS 2018

2018-10-15

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.

Investors

Investor updates
view all

stay updated

get the latest news and updates to your inbox.